Our Therapeutic Antibody Discovery Platforms
Access a full suite of technologies that transform the transgenic animal approach to the discovery of fully human antibodies
Learn about our computationally powered antigen design platform for challenging therapeutic targets.
Robust high-throughput screening enables deep searches into immune repertoires to identify unique antibodies with a superior target profile.
Leverage the full suite of OmniAb technologies for enhanced discovery and optimization.
Partnerships with Contract Research Organizations (CROs)
OmniAb works with a comprehensive network of international contract research organizations (CROs) with substantial experience generating OmniAb antibodies and with expertise in characterization, bioinformatics, cell line development, and GMP manufacturing. Current CROs include: